COCRYSTAL PHARMA, INC. Current Liabilities
COCRYSTAL PHARMA, INC. (COCP) had Current Liabilities of $2.62 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $2.62M.
- 2026-03-31: Liabilities, Current $2.23M.
- 2025-12-31: Liabilities, Current $2.21M.
- 2025-09-30: Liabilities, Current $1.52M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.62M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.23M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.21M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.52M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.83M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.93M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.43M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.95M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.65M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.38M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $3.26M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.92M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.59M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.15M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.62M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.81M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.54M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.23M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.38M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.36M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $2.61M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $2.94M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.93M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $2.29M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $2.10M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.85M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.75M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.56M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.14M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.05M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.36M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.44M 10-K · filed 2019-04-01 | $1.41M 10-K · filed 2018-03-21 |
| 2017-09-30 | $1.76M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.80M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.03M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.04M 10-K · filed 2018-03-21 | |
| 2016-09-30 | $3.15M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.38M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.89M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $6.70M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $4.15M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $7.35M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $14.65M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $9.16M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $7.66M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.91M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.55M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $386.00K 10-K · filed 2015-03-31 | $12.48M 10-K · filed 2014-03-31 |
| 2013-09-30 | $15.29M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $10.43M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $9.21M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $10.82M 10-K · filed 2014-03-31 | $7.93M 10-K · filed 2013-04-01 |
| 2012-09-30 | $5.42M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $10.05M 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $10.77M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $7.28M 10-K · filed 2013-04-01 | |
| 2011-09-30 | $7.80M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $7.54M 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $5.08M 10-K · filed 2012-04-16 | $4.80M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |